newsfilter
← Latest News
GlobeNewswire·

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

How Parkinson's affects million – and why current treatments are not enoughContinuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson's careSerina's drug candidate SER-252 is designed to deliver